-- GSK Plc and Pfizer Inc.’s vaccines for a common respiratory virus must carry warnings that they may be tied to an increased risk of a rare neurological side effect that can lead to paralysis, the US Food and Drug Administration said. A study done after the respiratory syncytial virus shots were approved suggests that people given GSK’s Arexvy and …
